Literature DB >> 27344146

Altered PPARγ Coactivator-1 Alpha Expression in Abdominal Aortic Aneurysm: Possible Effects on Mitochondrial Biogenesis.

Marike Gabrielson1, Emina Vorkapic, Maggie Folkesson, Martin Welander, Andreas Matussek, Jan Dimberg, Toste Länne, Josefin Skogberg, Dick Wågsäter.   

Abstract

INTRODUCTION: Abdominal aortic aneurysm (AAA) is a complex and deadly vascular disorder. The pathogenesis of AAA includes destruction and phenotypic alterations of the vascular smooth muscle cells (VSMCs) and aortic tissues. PPARγ coactivator-1 alpha (PGC1α) regulates VSMC migration and matrix formation and is a major inducer of mitochondrial biogenesis and function, including oxidative metabolism.
METHODS: Protein and gene expression of PGC1α and markers for mitochondria biogenesis and cell type-specificity were analysed in AAA aortas from humans and mice and compared against control aortas.
RESULTS: Gene expression of PPARGC1A was decreased in human AAA and angiotensin (Ang) II-induced AAA in mice when compared to control vessels. However, high expression of PGC1α was detected in regions of neovascularisation in the adventitia layer. In contrast, the intima/media layer of AAA vessel exhibited defective mitochondrial biogenesis as indicated by low expression of PPARGC1A, VDAC, ATP synthase and citrate synthase.
CONCLUSION: Our results suggest that mitochondrial biogenesis is impaired in AAA in synthetic SMCs in the media, with the exception of newly formed supporting vessels in the adventitia where the mitochondrial markers seem to be intact. To our knowledge, this is the first study investigating PGC1α and mitochondria biogenesis in AAA.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27344146     DOI: 10.1159/000446653

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  5 in total

1.  Late onset MELAS with m.3243A > G mutation and its association with aneurysm formation.

Authors:  Kun Zhu; Shuang Li; Huan Chen; Yao Wang; Miao Yu; Hongyan Wang; Weijie Zhao; Yunpeng Cao
Journal:  Metab Brain Dis       Date:  2017-03-21       Impact factor: 3.584

2.  Targeting mitochondrial fission as a potential therapeutic for abdominal aortic aneurysm.

Authors:  Hannah A Cooper; Stephanie Cicalese; Kyle J Preston; Tatsuo Kawai; Keisuke Okuno; Eric T Choi; Shingo Kasahara; Haruhito A Uchida; Nozomu Otaka; Rosario Scalia; Victor Rizzo; Satoru Eguchi
Journal:  Cardiovasc Res       Date:  2021-02-22       Impact factor: 10.787

3.  Mitochondrial function in thoracic aortic aneurysms.

Authors:  Emma Yu; Kirsty Foote; Martin Bennett
Journal:  Cardiovasc Res       Date:  2018-11-01       Impact factor: 10.787

Review 4.  Aberrant Mitochondrial Dynamics: An Emerging Pathogenic Driver of Abdominal Aortic Aneurysm.

Authors:  Mingqi Ouyang; Mi Wang; Bilian Yu
Journal:  Cardiovasc Ther       Date:  2021-06-16       Impact factor: 3.023

5.  Decreased mitochondrial respiration in aneurysmal aortas of Fibulin-4 mutant mice is linked to PGC1A regulation.

Authors:  Ingrid van der Pluijm; Joyce Burger; Paula M van Heijningen; Arne IJpma; Nicole van Vliet; Chiara Milanese; Kees Schoonderwoerd; Willem Sluiter; Lea-Jeanne Ringuette; Dirk H W Dekkers; Ivo Que; Erik L Kaijzel; Luuk Te Riet; Elena G MacFarlane; Devashish Das; Reinier van der Linden; Marcel Vermeij; Jeroen A Demmers; Pier G Mastroberardino; Elaine C Davis; Hiromi Yanagisawa; Harry C Dietz; Roland Kanaar; Jeroen Essers
Journal:  Cardiovasc Res       Date:  2018-11-01       Impact factor: 10.787

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.